Wealth Alliance’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Sell
15,844
-338
-2% -$23.3K 0.12% 156
2025
Q1
$1.12M Buy
16,182
+4,853
+43% +$337K 0.14% 148
2024
Q4
$975K Sell
11,329
-249
-2% -$21.4K 0.12% 163
2024
Q3
$1.38M Buy
11,578
+15
+0.1% +$1.79K 0.16% 121
2024
Q2
$1.65M Buy
11,563
+245
+2% +$35K 0.21% 89
2024
Q1
$1.45M Sell
11,318
-518
-4% -$66.5K 0.19% 113
2023
Q4
$1.22M Buy
11,836
+313
+3% +$32.4K 0.17% 119
2023
Q3
$1.05M Buy
11,523
+841
+8% +$76.5K 0.17% 125
2023
Q2
$864K Sell
10,682
-666
-6% -$53.9K 0.13% 166
2023
Q1
$903K Sell
11,348
-1,018
-8% -$81K 0.15% 152
2022
Q4
$837K Buy
12,366
+1,232
+11% +$83.4K 0.15% 157
2022
Q3
$555K Buy
11,134
+2,370
+27% +$118K 0.11% 193
2022
Q2
$488K Sell
8,764
-1,390
-14% -$77.4K 0.09% 218
2022
Q1
$564K Buy
10,154
+256
+3% +$14.2K 0.12% 193
2021
Q4
$554K Sell
9,898
-38
-0.4% -$2.13K 0.11% 205
2021
Q3
$477K Sell
9,936
-250
-2% -$12K 0.11% 214
2021
Q2
$427K Buy
10,186
+2
+0% +$84 0.1% 233
2021
Q1
$343K Buy
10,184
+150
+1% +$5.05K 0.1% 257
2020
Q4
$350K Sell
10,034
-680
-6% -$23.7K 0.1% 247
2020
Q3
$372K Buy
10,714
+144
+1% +$5K 0.13% 184
2020
Q2
$346K Buy
10,570
+1,292
+14% +$42.3K 0.14% 194
2020
Q1
$279K Buy
+9,278
New +$279K 0.15% 172